NovMetaPharma Co., Ltd. (XKON:229500)
South Korea · Delayed Price · Currency is KRW 7,800.00
-150.00 (-1.89%)
At close: Jun 5, 2026
NovMetaPharma Market Cap
NovMetaPharma has a market cap or net worth of 100.16 billion as of June 5, 2026. Its market cap has increased by 3.78% in one year.
Market Cap
100.16B
Enterprise Value
n/a
Revenue
1.30B
Ranking
n/a
PE Ratio
65.00
Stock Price
7,800.00
Market Cap Chart
Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 100.16B, an increase of 34.28%. That is a compound annual growth rate of 3.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 100.16B | -38.81% |
| Dec 30, 2025 | 163.69B | 187.16% |
| Dec 30, 2024 | 57.00B | -46.33% |
| Dec 29, 2022 | 106.21B | -45.89% |
| Dec 30, 2021 | 196.29B | -9.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prestige Biologics | 142.13B |
| ISU Abxis | 132.93B |
| CORESTEMCHEMON | 129.31B |
| Cell Biotech | 111.76B |
| QuadMedicine | 94.38B |
| Choong Ang Vaccine Laboratory | 87.87B |
| BIO-FD&C | 84.44B |
| CTCBIO | 78.30B |